Dermatology Advisor (4/18, Kuhns) reported on a study finding that “oral finasteride use at various doses was associated with completed suicide, depression suicidal, suicidal behavior, and suicidal ideation following the identification of post-finasteride syndrome, but was not associated with suicide attempts.” The study was based on “data from the United States Food and Drug Administration Adverse Event Reporting System (FAERS).” The findings were published in the Journal of Cosmetic Dermatology. Finasteride is used to treat Benign Prostatic Hypertrophy and men’s pattern baldness.
Related Links:
— “Oral Finasteride Associated With Increased Depression, Suicidal Ideation Rates,” Lisa Kuhns, PhD, Dermatology Advisor, April 18, 2025